GlobeNewswire 12/6/2021 Adverum Biotechnologies Appoints Rupert D’Souza, Ph.D., M.B.A. as Chief Financial Officer
GlobeNewswire 11/4/2021 Adverum Reports Third Quarter 2021 Results
GlobeNewswire 10/9/2021 Adverum Presents Clinical Data on ADVM-022 at the American Society of Retina Specialists 39th Annual...
GlobeNewswire 10/1/2021 Adverum Presents 2-Year OPTIC Data Demonstrating Sustained Durability and Promising Safety Profile f...
GlobeNewswire 9/27/2021 Adverum to Present Data from ADVM-022 Clinical Trials at Upcoming Medical Conferences
GlobeNewswire 9/9/2021 Lycia Therapeutics Announces $70 Million Series B Financing Led by Redmile Group with Participation ...
GlobeNewswire 8/23/2021 Adverum Appoints Global Regulatory Leader Jim Wang, Ph.D., as Senior Vice President, Head of Regulat...
GlobeNewswire 8/5/2021 Adverum Reports Second Quarter 2021 Results
GlobeNewswire 7/22/2021 Adverum Provides Update on ADVM-022 and the INFINITY Trial in Patients with Diabetic Macular Edema
GlobeNewswire 7/1/2021 Adverum Announces Appointment of Jon Williams, Ph.D., as Vice President, Clinical Affairs
GlobeNewswire 6/24/2021 Adverum Announces Changes to Management Team
GlobeNewswire 6/1/2021 Adverum Appoints CMO and CSO
GlobeNewswire 5/12/2021 Adverum Stockholders Re-Elect All Adverum Director Nominees at 2021 Annual Meeting
GlobeNewswire 5/10/2021 Adverum Issues Statement Regarding Upcoming Annual Meeting of Stockholders
GlobeNewswire 5/6/2021 Adverum Reports First Quarter 2021 Results
GlobeNewswire 5/1/2021 Adverum Biotechnologies Presents Long-term Data through March 10, 2021 from the OPTIC Trial of ADVM-...
GlobeNewswire 4/28/2021 Adverum Biotechnologies Provides Update on the INFINITY Trial Evaluating ADVM-022 in Patients with D...
GlobeNewswire 4/27/2021 Aligos Therapeutics Appoints James Scopa, J.D., MBA, to its Board of Directors
GlobeNewswire 4/22/2021 Adverum Files Investor Presentation Highlighting Significant Strategic Progress and Purpose-Built Bo...
GlobeNewswire 4/21/2021 Adverum Mails Letter to Stockholders Highlighting World-Class Board of Directors Overseeing Successf...
GlobeNewswire 4/16/2021 Adverum Biotechnologies to Present New Data from the OPTIC Trial of ADVM-022 Intravitreal Gene Thera...
GlobeNewswire 4/15/2021 Adverum Files Definitive Proxy Materials and Mails Letter to Stockholders Detailing Strength of Team...
GlobeNewswire 3/30/2021 Adverum Announces Senior Appointments for Patient Access and Clinical Operations as ADVM-022 Advance...
GlobeNewswire 3/18/2021 Adverum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 3/17/2021 Adverum Announces Board Slate for 2021 Annual Meeting and Reiterates Commitment to Stockholder Value...